COAGULATION DISORDER

Clinical trials for COAGULATION DISORDER explained in plain language.

Never miss a new study

Get alerted when new COAGULATION DISORDER trials appear

Sign up with your email to follow new studies for COAGULATION DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1 Completed 2

Race against time: new drug aims to stop bleeding in emergency surgery patients

Disease control Recruiting now

This study compares a new drug called TAK-330 against standard treatment to quickly reverse blood thinners in people who need emergency surgery. Adults taking common blood thinners like apixaban or rivaroxaban who require urgent procedures with high bleeding risk may participate.…

Matched conditions: COAGULATION DISORDER

Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

COAGULATION DISORDER

Get alerted when new COAGULATION DISORDER trials appear

Race against time: new drug aims to stop bleeding in emergency surgery patients